Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan-Dec:31:10760296251347630.
doi: 10.1177/10760296251347630. Epub 2025 Jun 2.

Investigation of Two Potential Predictors of Thrombosis Risk in Polycythemia Vera: Hematocrit-to-Hemoglobin Ratio and HALP Score

Affiliations

Investigation of Two Potential Predictors of Thrombosis Risk in Polycythemia Vera: Hematocrit-to-Hemoglobin Ratio and HALP Score

Deniz Yilmaz et al. Clin Appl Thromb Hemost. 2025 Jan-Dec.

Abstract

Objective: This study aimed to assess the utility of the hematocrit-to-hemoglobin ratio (HHR) and the HALP score in detecting thrombosis history in patients with polycythemia vera (PV). Methods: This retrospective study examined patients diagnosed with PV between January 2013 and December 2022. Demographics, clinical history, PV- and thrombosis-related data, laboratory findings, follow-up duration, and mortality status were retrieved from hospital records. HHR and HALP scores were calculated for all patients. Patients were grouped based on their thrombosis history. Results: A total of 124 PV patients were included, with a mean age of 57.65 ± 12.17 years, and 86 (69.35%) were males. Thrombosis was present in 59 patients (47.58%), with 32.20% occurring before diagnosis, 23.73% at diagnosis, and 44.07% after diagnosis. Patients with and without thrombosis history were similar in age and sex. Those with a history of thrombosis had significantly higher anticoagulant use and HHR values, while other variables, including HALP score, showed no differences. An HHR cut-off value of >3.05 predicted thrombosis history with 54.24% sensitivity and 72.31% specificity. Conclusion: HHR could help distinguish PV patients with thrombosis history, though its sensitivity is low. HALP score was not associated with thrombosis risk.

Keywords: hematocrit; hemoglobins; polycythemia vera; risk factors; thrombosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
ROC Curves of the HHR Value and HALP Score to Discriminate Thrombosis History.

Similar articles

References

    1. Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(9):1465-1487. doi:10.1002/ajh.27002 - DOI - PubMed
    1. Szuber N, Mudireddy M, Nicolosi M, et al. 3023 Mayo clinic patients with myeloproliferative neoplasms: Risk-stratified comparison of survival and outcomes data among disease subgroups. Mayo Clin Proc. 2019;94(4):599-610. doi:10.1016/j.mayocp.2018.08.022 - DOI - PubMed
    1. Yalçınkaya R, Zenciroğlu A. Evaluation of neonatal polycythemia in terms of gestational age, hematocrit, and platelet levels. Turk J Pediatr Dis. 2022;16(6):495-500. doi:10.12956/tchd.1016684 - DOI
    1. Marchioli R, Finazzi G, Landolfi R, et al. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol. 2005;23(10):2224-2232. doi:10.1200/jco.2005.07.062 - DOI - PubMed
    1. Barbui T, Carobbio A, Rumi E, et al. In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood. 2014;124(19):3021-3023. doi:10.1182/blood-2014-07-591610 - DOI - PubMed

LinkOut - more resources